Treatment with tumor necrosis factor inhibitors and the risk of acute coronary syndromes in early rheumatoid arthritis
Authors:
- Lotta LjungLLLotta Ljung
- Julia F. SimardJSJulia F. Simard
- Solbritt Rantapää‐DahlqvistSRSolbritt Rantapää‐Dahlqvist
- Anti‐Rheumatic Therapy in Sweden (ARTIS) Study GroupAGAnti‐Rheumatic Therapy in Sweden (ARTIS) Study Group
Open Access
- 26 August 2011
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 64 (1) , 42-52
Abstract
Objective: Rheumatoid arthritis (RA) is associated with an increased risk of ischemic heart disease, in both early and established RA. Data on the risk of ischemic heart disease in relation to therapy with tumor necrosis factor (TNF) antagonists (anti‐TNF) are conflicting in patients with established RA and essentially lacking in those with early RA. In established RA, the risk of myocardial infarction has been linked to the response to anti‐TNF therapies. The aim of this study was to determine the risk of acute coronary syndromes (ACS) in patients with early RA in relation to treatment with, and response to, anti‐TNF.Methods: A cohort consisting of patients in whom RA was diagnosed between 1999 and 2007 was identified from the Swedish Rheumatology Register (n = 6,000), from which information on disease activity and pharmacologic treatments was extracted. In a cohort study, the risk of first occurrence of an ACS was compared between patients treated with anti‐TNF and those without exposure to anti‐TNF, using hazard ratios (HRs). In a nested case–control study, the relationship between response to anti‐TNF according to the European League Against Rheumatism (EULAR) response criteria and the risk of ACS was investigated.Results: In the cohort study, treatment with anti‐TNF was not related to any statistically significant alteration in the risk of ACS (HR 0.80, 95% confidence interval [95% CI] 0.52–1.24). In the nested case–control study, a good or moderate EULAR treatment response at 3 months and at 6 months was not associated with a risk of ACS (odds ratio [OR] 1.7, 95% CI 0.5–5.1 and OR 1.5, 95% CI 0.3–6.9, respectively), when adjusted for disease activity before treatment start.Conclusion: In this study of patients treated with anti‐TNF within the first years of RA, neither treatment with, nor response to, anti‐TNF therapy could be linked to any statistically significant decrease in the risk of ACS.Keywords
This publication has 47 references indexed in Scilit:
- Left ventricular structure and function in patients with rheumatoid arthritis, as assessed by cardiac magnetic resonance imagingArthritis & Rheumatism, 2010
- High ten‐year risk of cardiovascular disease in newly diagnosed rheumatoid arthritis patients: A population‐based cohort studyArthritis & Rheumatism, 2008
- Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti–tumor necrosis factor α therapy: Results from the British Society for Rheumatology Biologics RegisterArthritis & Rheumatism, 2007
- Severe extra-articular disease manifestations are associated with an increased risk of first ever cardiovascular events in patients with rheumatoid arthritisAnnals of the Rheumatic Diseases, 2007
- Inflammation, Atherosclerosis, and Coronary Artery DiseaseNew England Journal of Medicine, 2005
- Development and validation of the european league against rheumatism response criteria for rheumatoid arthritis: Comparison with the preliminary american college of rheumatology and the world health organization/international league against rheumatism criteriaArthritis & Rheumatism, 1996
- Modified disease activity scores that include twenty-eight-joint counts development and validation in a prospective longitudinal study of patients with rheumatoid arthritisArthritis & Rheumatism, 1995
- The mortality of rheumatoid arthritisArthritis & Rheumatism, 1994
- The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritisArthritis & Rheumatism, 1988
- Measurement of patient outcome in arthritisArthritis & Rheumatism, 1980